Asset
FIMEPINOSTAT
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02307240 | phase1 | completed | 2014-11-01 | 2019-05-31 | Curis, Inc. | Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors |
| NCT02674750 | phase2 | completed | 2016-07-01 | 2019-05-28 | Curis, Inc. | Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations |
FDA applications (0)
This company has no applications containing this asset.